Viking Therapeutics, Genfit, Sagimet jump as Novo to buy Akero
Source: SeekingAlpha
2025-10-09 11:33:30 ET
More on Akero Therapeutics, Novo Nordisk, etc.
- Novo Nordisk to Acquire Akero Therapeutics Inc.
- Novo Nordisk A/S (NVO) M&A Call Transcript
- Novo Nordisk: The Lack Of Pricing Power Is A Problem
- Akero Therapeutics soars on $5.2 billion acquisition deal with Novo Nordisk
- Novo Nordisk’s appeal to halt Medicare price negotiations rejected
Read the full article on Seeking Alpha
For further details see:
Viking Therapeutics, Genfit, Sagimet jump as Novo to buy Akero
Novo Nordisk A/S
NASDAQ: NVO
NVO Trading
0.23% G/L:
$38.55 Last:
8,866,235 Volume:
$38.58 Open:
NVO Latest News
March 06, 2026 06:25:00 pm
Down but Not Out: Is Novo Nordisk a Conditional Buy as Eli Lilly Leads the GLP?1 Market?
March 05, 2026 04:25:00 pm
Novo Nordisk's Obesity Setback: What Kagrama's Miss vs. Zepbound Means for Investors
NVO Stock Data
$220,548,675,000
4,194,421,000
N/A
749
N/A
Biotechnology & Life Sciences
Healthcare
DK
Bagsvaerd
